25 January 2024 in Annals of Medicine & Surgery
Objective: COVID-19 vaccination is recommended in diabetic patients since diabetes is associated with worse clinical outcomes in COVID-19 infection. The safety profile of different types of COVID-19 vaccines, especially on glycemic control, can be explored due to availability of data from continuous glucose monitoring (CGM) devices. This meta-analysis aimed to quantify the impact of COVID-19 vaccination on glycemic control in patients with type 1 diabetes mellitus (T1DM). Methods: A systematic search of PubMed, Embase, and Google Scholar was conducted using a search strategy for studies published till January 2023 in English language. Comparative observational studies reporting glycemic control obtained from CGM before and after COVID-19 vaccination in T1DM patients were included. The primary outcome was time in range (TIR) metric of proportion of glucose results falling within the range: 3.9–10 mmol/l. Other outcomes were time above range (TAR) (>10 mmol/l), time below range (TBR) (<3.9 mmol/l), coefficient of variation (CV), and mean blood glucose levels. The pooled outcomes were compared pre-vaccination and post-vaccination using Hedges’ g (HG) with 95% CI. Results: A total of seven studies (632 participants) were included in the meta-analysis. COVID-19 vaccination caused small and statistically insignificant decrease in TIR after both the first (HG = 0.21, 95% CI: −0.02 to 0.44, P=0.07) and second dose (HG = 0.09, 95% CI: −0.04 to 0.21, P = 0.19). Likewise, TAR was not affected after neither first (HG = −0.09, 95% CI: −0.22 to 0.03, P = 0.12) nor second vaccine dose (HG = −0.07, 95% CI: −0.21 to 0.06, P = 0.30). Likewise, TBR, mean blood glucose levels, and CV were not significantly altered following uptake of either of the doses. Conclusion: COVID-19 vaccination has an excellent safety profile in T1DM patients owing to its minimal impacts on immediate glycemic control.
3 January 2024 in Annals of Medicine & Surgery
Introduction: Endometrial polyps (EPs) result from the overgrowth of endometrial glands and stroma. Giant endometrial polyps, defined as those exceeding 4 cm, are rare, and their association with phytoestrogen (PE) intake is infrequently reported. Case presentation: The authors present a case of a giant endometrial polyp in a 59-year-old post-menopausal woman from Nepal. The patient presented with lower abdominal pain and a history of vaginal spotting. She was not under any drugs or medications, including hormones, but had a regular intake of PE-rich foods. Imaging revealed a giant endometrial polyp and a uterine fibroid. Total abdominal hysterectomy and bilateral salpingo-oophorectomy (TAH-BSO) were performed and histopathology examination confirmed the diagnosis of endometrial polyp and fibroid. Discussion: In our case, the patient’s increased age and PE-rich diet were identified as potential risk factors for the giant endometrial polyp. Giant endometrial polyps are rare, with limited cases reported to date, often associated with tamoxifen or raloxifene use. Phytoestrogens can exhibit oestrogenic effects, contributing to endometrial polyps. This case emphasizes the importance of further research to explain the relationship between phytoestrogen intake and giant endometrial polyps. Conclusion: Giant endometrial polyps are uncommon, and their association with phytoestrogen intake remains underexplored. Clinicians should consider dietary factors in history while evaluating endometrial polyps, and further research is necessary to explore the potential role of phytoestrogens in the development of giant endometrial polyps.
27 October 2025 in Clinical Case Reports
Transorbital penetrating intracranial injury (TOPI) is a rare form of traumatic brain injury, often caused by high‐velocity projectiles. However, non‐missile penetrating injuries, particularly from wooden foreign bodies, are uncommon and pose diagnostic and therapeutic challenges due to their radiolucency and high risk of infection. We report the case of a 58‐year‐old Nepali male who sustained a TOPI after falling from a tree, with a wooden foreign body penetrating his right orbit and extending intracranially. The patient presented 6 days post‐injury with persistent pain and bleeding but no neurological deficits. Imaging revealed a comminuted fracture of the superomedial orbital wall with intracranial extension, an intraorbital foreign body, and vascular compromise in the anterior cerebral artery (ACA) territory. Given the intracranial extension and vascular involvement, a multidisciplinary approach involving neurosurgery and ophthalmology was employed. The foreign body was successfully removed via a medial orbitotomy, and the patient was managed with broad‐spectrum antibiotics. His postoperative course was uneventful, with no long‐term complications. TOPI involving wooden foreign bodies presents diagnostic difficulties due to their variable CT attenuation and potential to mimic pneumocephalus. MRI is often required for definitive diagnosis, but in resource‐limited settings, a combination of clinical evaluation and CT with angiography can guide management. Early surgical removal and infection control are critical for a favorable outcome. Various surgical approaches, including orbitotomy, transcranial, and transnasal endoscopic techniques, should be considered based on foreign body location and extent. This case underscores the importance of early recognition, multimodal imaging, and timely surgical intervention in managing TOPI. Despite the high‐risk nature of such injuries, meticulous planning and prompt treatment can lead to excellent functional and neurological recovery.
1 September 2025 in Annals of Medicine & Surgery
Non-alcoholic fatty liver disease (NAFLD) is a common metabolic disorder with no definite universal pharmacotherapy. Recent studies have demonstrated that sodium-glucose co-transporter-2 inhibitors (SGLT2i) have the potential to improve body fat composition and hepatic steatosis. This narrative review explores the beneficial effects of SGLT2i on visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT), and liver fat in NAFLD patients. This review identified studies evaluating the effect of SGLT2is on imaging biomarkers (MRI-proton density fat fraction [PDFF%], FibroScan-CAP, liver-to-spleen attenuation ratio) and body fat composition metrics. Among 16 studies assessing VAT, 14 reported significant reductions, attributed to caloric loss and improved insulin sensitivity. Hepatic steatosis, measured with CAP scores, showed a modest decrease (mean difference: −10.59 dB/m vs. controls). Likewise, MRI-PDFF% demonstrated significant absolute reductions ranging from 2.23% to 9.9%. Overall, SGLT2i modestly improve VAT and hepatic steatosis in NAFLD, but their role should complement lifestyle interventions. There is a need for long-term trials to assess histologic endpoints and clinical outcomes.
6 October 2025 in Clinical Case Reports
Moyamoya disease (MMD) is a rare progressive cerebrovascular disorder characterized by stenosis of the terminal internal carotid arteries with fragile collateral vessel formation. It is common in East Asia but underreported in Nepal. Pediatric cases typically present with ischemic symptoms such as transient ischemic attacks, stroke, or seizures. We report a 7‐year‐old Nepali boy with 11 days of fever followed by recurrent tonic–clonic seizures, progressive right‐sided weakness, and impaired fine motor function. Examination showed right hemiparesis with an upgoing plantar reflex. MRI and MR angiography revealed multiple acute infarcts with supraclinoid internal carotid artery stenosis and extensive collateral vessels, confirming MMD. Cerebrospinal fluid and autoimmune workup were unremarkable. The child was managed conservatively with aspirin and levetiracetam, leading to partial recovery. Surgery was deferred due to financial limitations and initial improvement. This case underscores the importance of considering MMD in pediatric strokes in non‐endemic regions. In resource‐limited settings like Nepal, conservative treatment offers symptomatic relief, but long‐term follow‐up is essential to monitor progression and surgical needs.
12 May 2025 in Annals of Medicine & Surgery
Introduction: Chyluria is a rare condition characterized by milky urine usually occurring due to rupture of lymphatic channels into the urinary system. Common symptoms include milky urine, clot colic, urinary retention, weight loss, edema, etc. Diagnosis is based on clinical suspicion, laboratory tests and imaging techniques such as USG, CT, MRI, and lymphangioscintigraphy. Management is based on dietary modifications, pharmacological treatment, minimally invasive endoscopic sclerotherapy, and laparoscopic chylolymphatic disconnection. Other procedures such as lymphovenous anastomosis or simple nephrectomy can also be adapted. Case description: A 33-year-old female from a filariasis endemic region of Nepal presented with chief complaints of whitish urine for 15 months associated with weight loss. The patient was initially treated with diethylcarbamazine (DEC) for 21 days, a year ago with some dietary modifications. She also underwent two episodes of endoscopic sclerosant instillations. The immunochromatographic test for filariasis was positive. Milky efflux was seen from the left ureteric orifice. Retrograde pyelography showed lymphatic backflow. The patient was managed with laparoscopic left chylolymphatic disconnection (Hilar stripping and nephron lympholysis), and the symptoms resolved. Discussion: Refractory cases of chyluria require surgical intervention to prevent long-term morbidity. Traditional open surgical ligation and excision of renal pedicle lymphatics are replaced by the minimally invasive approach of retroperitoneoscopy. The laparoscopic method is a preferred treatment as it has minimal incision-related morbidity and is safe, effective, and efficient. Other surgical options include lymphovenous anastomosis or renal autotransplantation. Conclusion: This case highlights the success of surgical intervention in treating refractory chyluria. Chylolymphatic disconnection could be safely performed with a laparoscopic approach without significant complications and reoccurrence.